Search Results - Alfred Cheng
- Showing 1 - 1 results of 1
-
1
Epigenetic therapeutics to overcome resistance against immune checkpoint inhibitors (ICI) in hepatocellular carcinoma (HCC): a proof-of-concept clinical trial by Stephen Chan, Alfred Cheng, Nick La Thangue, David Kerr
Published in The Lancet Regional Health. Western Pacific (2025-02-01)Get full text
Article